Cargando…

Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy

Breast cancer (BC) is the most common type of cancer in women and, in most cases, it is hormone-dependent (HD), thus relying on ovarian hormone activation of intracellular receptors to stimulate tumor growth. Endocrine therapy (ET) aimed at preventing hormone receptor activation is the primary treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araújo, Rita, Fabris, Victoria, Lamb, Caroline A., Lanari, Claudia, Helguero, Luisa A., Gil, Ana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921989/ https://www.ncbi.nlm.nih.gov/pubmed/35299741 http://dx.doi.org/10.3389/fonc.2022.786931

Ejemplares similares

Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures
por: Bispo, Daniela, et al.
Publicado: (2020)

Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice
por: Lamb, Caroline A, et al.
Publicado: (2005)

Editorial: Steroid hormone receptors and cell cycle in breast cancer
por: Fabris, Victoria T., et al.
Publicado: (2023)

Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth
por: Fabris, Victoria T, et al.
Publicado: (2010)

Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014)

Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
por: Qin, Ruoyan, et al.
Publicado: (2023)

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor– positive early breast cancer
por: Verma, S., et al.
Publicado: (2009)

Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer
por: Sehdev, S., et al.
Publicado: (2009)

Impact of physical exercise programs in breast cancer survivors on health-related quality of life, physical fitness, and body composition: Evidence from systematic reviews and meta-analyses
por: Joaquim, Ana, et al.
Publicado: (2022)

Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
por: Wu, Yun, et al.
Publicado: (2021)

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
por: Leung, Euphemia Y., et al.
Publicado: (2017)

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
por: Tolaney, Sara M., et al.
Publicado: (2022)

Unveiling the Impact of Morphine on Tamoxifen Metabolism in Mice in vivo
por: Gabel, Florian, et al.
Publicado: (2020)

Dysregulation of Transcription Factor Networks Unveils Different Pathways in Human Papillomavirus 16-Positive Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix
por: Bispo, Saloe, et al.
Publicado: (2021)

Nuclear Mechanisms Involved in Endocrine Resistance
por: Dittmer, Jürgen
Publicado: (2021)

Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials
por: El Sayed, Rola, et al.
Publicado: (2019)

Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials
por: Xie, Ming, et al.
Publicado: (2022)

Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials
por: Hu, Qiancheng, et al.
Publicado: (2023)

Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment
por: Chen, Yun-Wang, et al.
Publicado: (2022)

A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
por: Li, Zijian, et al.
Publicado: (2022)

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
por: Lambertini, Matteo, et al.
Publicado: (2019)

Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2014)

Unveiling Stem Cell Kinetics: Prime Time for Integrating Experimental and Computational Models
por: Enderling, Heiko
Publicado: (2013)

Unveiling novel insights in prostate cancer through single-cell RNA sequencing
por: Yu, Wenyue, et al.
Publicado: (2023)

Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
por: Cao, Lifen, et al.
Publicado: (2021)

Development and evaluation of a psychosocial adaptation questionnaire for women with breast cancer treated with adjuvant endocrine therapy: a single-centre, cross-sectional study in China
por: Jiang, Haoran, et al.
Publicado: (2022)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Co-occurrence of Dermatomyositis and Polycythemia Unveiling Rare de Novo Neuroendocrine Prostate Tumor
por: Papagoras, Charalampos, et al.
Publicado: (2018)

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma
por: Huo, Yansong, et al.
Publicado: (2022)

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
por: Grigore, Alexandru Dan, et al.
Publicado: (2015)

The Role of Lithium in Management of Endocrine Tumors—A Comprehensive Review
por: Thakur, Shilpa, et al.
Publicado: (2019)

Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer
por: Gelissen, Julia H., et al.
Publicado: (2022)

Endocrine-disrupting chemicals and breast cancer: a meta-analysis
por: Liu, Haiyan, et al.
Publicado: (2023)

Overlap of Endocrine Hormone Expression in the Mouse Intestine Revealed by Transcriptional Profiling and Flow Cytometry
por: Habib, Abdella M., et al.
Publicado: (2012)

Hormone Production in Endocrine Tumours
por: Abelson, Denis
Publicado: (1958)

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
por: Elía, Andrés, et al.
Publicado: (2023)

Evolution of Advanced Chronic Lymphoid Leukemia Unveiled by Single-Cell Transcriptomics: A Case Report
por: Ostasov, Pavel, et al.
Publicado: (2020)

Laparoscopic Gastrectomy for Cancer: Cut Down Complications to Unveil Positive Results of Minimally Invasive Approach
por: Bjelovic, Milos, et al.
Publicado: (2022)

Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
por: Yue, Yanhua, et al.
Publicado: (2022)

Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6v8vgjue4bkq8tp7h89tk7odlc